Weight Loss in Owings Mills

Medical Weight Loss in Owings Mills, Maryland: Physician-Supervised Program with Tirzepatide and Semaglutide for Sustainable Fat Loss

FDA-Approved Medications Combined with Metabolic Assessment, Personalized Nutrition, and Medical Monitoring for Lasting Results

Traditional dieting and exercise alone fail for millions of people each year. If you’ve lost weight multiple times only to regain it, or struggled despite consistent effort, the problem may not be willpower—it may be your metabolism. Dermatology Laser Center and MediSpa in Owings Mills, Maryland offers a physician-supervised medical weight loss program combining FDA-approved prescription medications, comprehensive metabolic assessment, personalized nutrition planning, and ongoing medical monitoring to achieve sustainable fat loss and long-term weight maintenance.

Under the direct care of Dr. Steven Barry Snyder, MD, board-certified dermatologist and cosmetic laser surgeon, our weight loss program is customized to your unique physiology, medical history, lifestyle, and goals. Unlike over-the-counter supplements or trend-based diets, our medically guided approach uses proven pharmaceutical and behavioral strategies to address the root metabolic and hormonal factors driving weight gain—delivering real, measurable results.

Call (410) 356-0000 or schedule your comprehensive weight loss consultation today. Dr. Snyder will assess your candidacy for medication-supported weight loss and design a personalized protocol to help you achieve your goals safely and effectively.

Understanding GLP-1 Receptor Agonists: How Semaglutide Works for Weight Loss

Semaglutide (brand names Ozempic, Wegovy, or Rybelsus) is an FDA-approved medication originally developed for type 2 diabetes that has proven revolutionary for sustainable weight loss, even in non-diabetic patients. Understanding how it works clarifies why medical weight loss is fundamentally different from traditional dieting.

The GLP-1 Hormone and Appetite Regulation:

Glucagon-like peptide-1 (GLP-1) is a natural hormone your intestines release in response to eating. GLP-1 has multiple critical roles in metabolism:

• Appetite Suppression: GLP-1 signals the brain’s appetite centers (hypothalamus and brainstem) to reduce hunger and food cravings. Higher GLP-1 levels = less desire to eat.
• Satiety Enhancement: GLP-1 increases feelings of fullness and satisfaction, so you naturally eat less before feeling overly full.
• Slowed Gastric Emptying: GLP-1 slows the rate at which food leaves your stomach, prolonging the sensation of fullness and reducing the drive to eat again soon after meals.
• Glucose Regulation: GLP-1 stimulates insulin secretion when blood sugar rises (after eating), helping stabilize blood glucose and reduce energy crashes that trigger cravings.
• Improved Insulin Sensitivity: GLP-1 enhances insulin action, improving your body’s ability to process and utilize glucose for energy rather than storing it as fat.

The Problem: Insufficient GLP-1 in People with Weight Gain and Metabolic Dysfunction

In people with obesity or metabolic syndrome, GLP-1 signaling is often blunted or dysregulated. The body produces GLP-1, but the appetite-suppression response is weakened, leading to:

• Persistent hunger despite adequate calorie intake
• Reduced satiety signals (feeling full is harder to achieve)
• Rapid gastric emptying (food moves through the stomach quickly, reducing fullness duration)
• Poor glucose control (blood sugar spikes and crashes trigger cravings)
• Lower insulin sensitivity (more food is stored as fat rather than used for energy)

This is why people with these metabolic patterns struggle: they are fighting against blunted biological signals, not personal weakness.

How Semaglutide Works: Restoring GLP-1 Function

Semaglutide is a GLP-1 receptor agonist—a medication that mimics and amplifies GLP-1 signaling throughout the brain and body. Weekly semaglutide injections:

• Restore Appetite Suppression: Semaglutide activates GLP-1 receptors in the hypothalamus and brainstem, effectively resetting appetite control and dramatically reducing hunger and cravings.
• Enhance Satiety: Patients feel fuller faster and stay satisfied longer, naturally reducing total calorie intake without conscious restriction or hunger torture.
• Slow Gastric Emptying: Food moves through the stomach more slowly, maintaining fullness sensations for hours rather than minutes.
• Stabilize Blood Glucose: Semaglutide improves glucose handling, reducing blood sugar spikes, crashes, and the cravings they trigger.
• Optimize Insulin Sensitivity: Improved insulin action directs calories toward energy use and muscle preservation rather than fat storage.
• Reduce Metabolic Adaptation: Weight loss typically triggers metabolic adaptation (your body reduces energy expenditure to conserve weight); semaglutide blunts this adaptation, maintaining metabolic rate despite calorie reduction.

Clinical Results with Semaglutide:

Landmark clinical trials demonstrate semaglutide’s efficacy:

• Average weight loss of 15–20% of starting body weight over 68 weeks (significantly higher than placebo or traditional weight loss approaches)
• Sustained weight loss across the 3-year study period with continued use
• Rapid initial weight loss (first 12 weeks) followed by continued gradual loss
• Improved cardiovascular outcomes and reduced cardiovascular event risk
• Better blood sugar control (even in non-diabetic patients, glucose levels improve)
• Improved lipid profiles (cholesterol and triglycerides often improve)
• Reduced blood pressure in many patients
• Safe profile across diverse populations

Tirzepatide: The Breakthrough Dual GIP/GLP-1 Receptor Agonist for Superior Weight Loss

While semaglutide is highly effective, a newer medication—tirzepatide (brand name Zepbound for weight loss; Mounjaro for diabetes)—represents a major advancement. Tirzepatide is the first dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, targeting two appetite and metabolism pathways simultaneously rather than one.

The GIP Hormone: A Second Mechanism of Appetite Control

GIP (glucose-dependent insulinotropic polypeptide, formerly “glucose-dependent insulinotropic peptide”) is a second natural hormone your intestines release when you eat, working in parallel with GLP-1. GIP plays distinct but complementary roles:

• Appetite Suppression Via Different Pathway: GIP activates appetite-suppression circuits distinct from GLP-1, providing additional inhibition of hunger signals from multiple brain regions simultaneously.
• Enhanced Satiety Signaling: GIP amplifies satiety through different neurobiological pathways than GLP-1, creating more powerful fullness signals.
• Metabolic Rate Support: GIP helps maintain metabolic rate during weight loss, counteracting metabolic adaptation—a critical advantage as weight loss typically decreases energy expenditure (making further loss harder).
• Energy Expenditure Optimization: GIP may increase calorie burning and fat oxidation, particularly brown adipose tissue (metabolically active fat) activation.
• Lean Muscle Preservation: By optimizing energy metabolism, GIP helps preserve muscle mass during weight loss, preventing the loss of metabolically active tissue that would lower resting metabolic rate.

Why Dual Action Matters: Tirzepatide’s Superior Efficacy

By targeting both GLP-1 and GIP pathways simultaneously, tirzepatide delivers:

• More Powerful Appetite Suppression: Two independent appetite-control systems suppressed simultaneously = stronger reduction in hunger and cravings than single-pathway medications.
• Greater Satiety: Dual activation of satiety signals throughout the brain creates more robust fullness, allowing smaller meals and longer intervals between eating.
• Improved Metabolic Rate Preservation: GIP’s unique role in metabolic rate support means tirzepatide-treated patients maintain higher metabolic rates during weight loss, making sustained fat loss easier.
• Superior Fat Loss with Muscle Preservation: The dual mechanism optimizes body composition—maximum fat loss with maximum muscle retention (important for health, strength, and long-term metabolic health).
• Improved Glucose and Lipid Control: Better blood sugar management and lipid profile improvements than semaglutide alone.
• Cardiovascular Benefits: Early data suggests tirzepatide may offer superior cardiovascular protection compared to GLP-1 alone.

Clinical Results with Tirzepatide:

Landmark SURMOUNT clinical trials demonstrate tirzepatide’s superiority to semaglutide:

• Average weight loss of 20–25% of starting body weight over 68 weeks (significantly higher than semaglutide’s 15–20%)
• Weight loss equivalent to some bariatric surgery outcomes without surgical risks or invasiveness
• Sustained weight loss with continued use; weight regain occurs if medication is discontinued
• Superior improvements in fasting glucose and HbA1c (long-term glucose control)
• Better lipid profile improvements (total cholesterol, LDL, triglycerides)
• Greater blood pressure reduction than semaglutide
• Demonstrated cardiovascular benefit and reduced cardiovascular event risk
• Safety profile similar to semaglutide with well-understood side effects
• Greater patient satisfaction due to superior results

Tirzepatide vs. Semaglutide: Which Is Right for You?

Both are FDA-approved and highly effective. Dr. Snyder will assess your:

• Starting weight and weight loss goals
• Baseline metabolic function and glucose control
• Previous weight loss attempts and metabolic responses
• Medical history and any contraindications
• Insurance coverage (tirzepatide is newer and may have different coverage)
• Personal preferences and side effect tolerance

Many patients begin with semaglutide (established, well-tolerated) and transition to tirzepatide if additional weight loss is needed. Some patients start directly with tirzepatide for maximum effect. Dr. Snyder will recommend the optimal choice for your situation.

The Medical Weight Loss Program: Comprehensive Assessment and Personalized Protocol

Our weight loss program is not a quick fix or temporary diet. It’s a comprehensive medical intervention addressing your unique metabolic profile and creating sustainable lifestyle change.

Phase 1: Comprehensive Medical Assessment (Week 1)

Before prescribing any medication, Dr. Snyder conducts a thorough evaluation:

• Medical History Review: Previous weight fluctuations, yo-yo dieting history, medication history, metabolic disorders, family history of obesity or metabolic disease, sleep patterns, stress levels, hormonal changes.
• Metabolic and Nutritional Assessment: Current eating patterns, food preferences, trigger foods, emotional eating patterns, barriers to healthy eating, current exercise habits and fitness level, lifestyle schedule and constraints.
• Physical Examination: Height, weight, waist circumference, body composition assessment (bioelectrical impedance or other methods to estimate muscle vs. fat), vital signs, cardiovascular assessment.
• Laboratory Testing: Fasting glucose, HbA1c (glucose control), fasting insulin (insulin resistance screening), comprehensive metabolic panel (kidney and liver function), lipid panel (cholesterol and triglycerides), thyroid function (TSH, free T4), assessment for metabolic syndrome and contraindications to medication.
• Candidacy Determination: Assessment of whether semaglutide, tirzepatide, or alternative approaches are appropriate based on your health profile.

Phase 2: Personalized Nutrition and Lifestyle Planning

Rather than restrictive dieting, our approach emphasizes sustainable, enjoyable eating habits:

• Nutrition Assessment and Personalized Plan: Based on your food preferences, cultural foods, lifestyle constraints, and metabolic needs, we develop a realistic eating plan you can maintain long-term—not a punitive diet but a sustainable way of eating that feels manageable and enjoyable.
• Macronutrient Optimization: Adequate protein intake (supports muscle preservation and satiety), healthy fat intake (supports hormone production and satiety), complex carbohydrate emphasis (stable blood sugar, sustained energy).
• Exercise Prescription: Realistic exercise plan tailored to your current fitness level, preferences, and schedule. Starting with achievable goals and progressively increasing intensity and duration. Exercise supports weight loss, preserves muscle, improves cardiovascular health, and boosts mental health.
• Behavioral Support: Strategies for managing emotional eating, stress eating, food cravings, and lifestyle obstacles to sustainable change. This may include referral to behavioral health specialists if emotional eating is a significant factor.
• Sleep Optimization: Sleep quality directly impacts weight loss success. We provide guidance on sleep hygiene, stress management, and other factors supporting quality sleep.
• Ongoing Education: Regular discussions about nutrition science, metabolism, weight loss physiology, and strategies for maintaining success during challenges or plateaus.

Phase 3: Medication Initiation and Titration

Once Dr. Snyder confirms candidacy and you commit to the lifestyle components, medication begins:

• Injection Training: For semaglutide or tirzepatide, we provide hands-on training in self-injection technique, timing, storage, and troubleshooting common questions.
• Starting Dose: Both medications begin at the lowest effective dose, allowing your body to adjust and minimizing initial side effects.
• Dose Escalation: Doses gradually increase every 4 weeks (for semaglutide) or every 4 weeks (for tirzepatide) until reaching the target dose—typically 2.4 mg weekly for semaglutide and 15 mg weekly for tirzepatide, though doses can vary based on response and tolerance.
• Baseline Side Effect Management: Most patients experience mild nausea, appetite reduction, or gastrointestinal effects during titration. These typically resolve within days to weeks as the body adjusts. We provide strategies to manage side effects and encourage continued use during this adaptation phase.
• Early Response Monitoring: Frequent check-ins during the first 4–8 weeks to monitor weight loss, side effects, medication tolerance, and adherence to nutrition/exercise plans.

Phase 4: Ongoing Monitoring and Optimization (Weeks 8+)

Long-term success depends on consistent follow-up and adjustment:

• Monthly Follow-Ups: Regular office visits (or telehealth options) to monitor weight loss progress, body measurements, side effects, nutrition/exercise adherence, and metabolic improvements.
• Periodic Laboratory Re-Assessment: Every 3–6 months, repeat key labs (glucose, HbA1c, lipids) to confirm metabolic improvements alongside weight loss.
• Body Composition Tracking: Beyond scale weight, we monitor body fat percentage, muscle mass, and waist circumference to ensure fat loss (not muscle loss) and optimal results.
• Medication Adjustments: If weight loss plateaus or side effects emerge, Dr. Snyder may adjust doses, switch medications, or modify the protocol to optimize results.
• Reinforcement of Lifestyle Changes: Ongoing support, education, and accountability for nutrition and exercise adherence. This is critical because lifestyle changes are what sustain results long-term.
• Psychological Support: For patients struggling with emotional eating, stress, body image, or motivation, referral to mental health support or coaching.

Phase 5: Long-Term Maintenance (Ongoing)

Weight loss success is only meaningful if results are sustained:

• Sustained Medication Use: Both semaglutide and tirzepatide must be continued indefinitely to maintain weight loss. Discontinuing medication typically results in weight regain over 6–12 months. Think of it like diabetes or blood pressure medication—chronic conditions require chronic treatment.
• Lifestyle Sustainability: The medication provides a window of opportunity to develop healthy eating and exercise habits. These habits, sustained long-term, are what prevent weight regain even if medication dose is eventually reduced or optimized.
• Periodic Re-Assessment: Annual comprehensive evaluations to confirm continued benefit, manage any late-emerging side effects, and adjust approach based on changing circumstances or goals.
• Complementary Treatments: After significant weight loss, many patients benefit from body contouring treatments to address loose skin. Options include EMSculpt NEO for muscle toning and fat reduction, Morpheus8 RF microneedling for skin tightening, and other aesthetic treatments to refine body contours and address skin laxity (these can begin 3–6 months into weight loss once significant fat loss has occurred).

Expected Timeline and Weight Loss Milestones

Weight loss occurs progressively, not overnight. Understanding realistic timelines helps maintain motivation and manage expectations:

Weeks 1–4 (Medication Initiation):

• Dose titration begins (typically lowest dose)
• Initial appetite reduction (hunger sensation noticeably decreases)
• Mild weight loss (2–5 lbs) as appetite decreases and calorie intake naturally reduces
• Possible mild nausea or GI effects (typically resolve within days to weeks)
• Assessment of medication tolerance and side effect management

Weeks 5–12 (Dose Escalation Phase):

• Continuing dose escalation toward therapeutic dose
• Progressive appetite suppression and improved satiety
• Accelerating weight loss (typically 2–3 lbs per week for many patients)
• Body beginning to notice changes in pants fit, energy levels
• Improved energy, mood, and mental clarity for many patients
• Baseline laboratory improvements (fasting glucose, HbA1c, lipids) often visible

Weeks 13–26 (First 6 Months):

• At target medication dose
• Steady, consistent weight loss (average 5–15 lbs per month for many patients)
• Visible physical changes: noticeable weight loss, clothes fitting differently, appearance changes
• Metabolic improvements: improved blood glucose control, improved blood pressure, improved lipid profiles
• Psychological improvements: increased confidence, improved body image, reduced weight-related anxiety
• Sustained appetite suppression allowing consistent adherence to nutrition plan

Months 6–12:

• Cumulative weight loss now substantial (20–50+ lbs for many patients depending on starting weight)
• Dramatic physical transformation visible to self and others
• Major health improvements: normalized blood glucose, resolved prediabetes, normalized blood pressure, improved cholesterol, resolved sleep apnea (if present), reduced joint pain, improved mobility
• Psychological transformation: significantly improved body confidence, reduced weight-related health anxiety, increased social engagement
• Possible weight loss plateau as body adjusts (normal; discussed with Dr. Snyder for protocol adjustment if needed)
• Consideration of complementary treatments: CoolSculpting for targeted fat reduction in localized areas, or skin tightening treatments as loose skin becomes apparent

Months 12+ (Long-Term):

• Reaching goal weight (or weight loss reaching plateau where further loss slows or plateaus)
• Transition to maintenance phase: medication dose optimized to maintain (rather than continue losing) weight
• Sustained metabolic health: normalized labs, improved cardiovascular health, reduced disease risk
• Sustained lifestyle changes: healthy eating and exercise habits now automatic and sustainable
• Long-term body contouring: if loose skin remains after weight stabilization, laser skin resurfacing and RF tightening treatments can improve appearance and confidence

Important Note on Weight Loss Rate:

Average weight loss with semaglutide is 1.5–3 lbs per week. With tirzepatide, average is 2–4 lbs per week. However, individual variation is significant—some patients lose faster, some slower, based on starting weight, metabolism, medication response, and adherence to nutrition/exercise. Dr. Snyder monitors your individual trajectory and adjusts approach to optimize your specific results.

Benefits of Medical Weight Loss Beyond the Scale

The true benefits of sustainable weight loss extend far beyond the number on the scale:

Metabolic and Health Benefits:

• Improved Glucose Control: Reversal of prediabetes, improved HbA1c, reduced risk of type 2 diabetes development or progression
• Improved Cardiovascular Health: Lower blood pressure, improved cholesterol and triglycerides, reduced cardiovascular event risk (heart attack, stroke)
• Reduced Inflammation: Weight loss and metabolic improvement reduce systemic inflammation, improving overall health and reducing disease risk
• Improved Sleep: Sleep apnea often resolves with weight loss; sleep quality and duration typically improve dramatically
• Reduced Joint Stress: Decreased load on joints improves pain and mobility, reducing risk of arthritis progression
• Improved Hormone Balance: Weight loss often normalizes hormonal dysfunction contributing to weight gain (improving thyroid function, cortisol regulation, reproductive hormone balance)
• Reduced Disease Risk: Lower risk of heart disease, stroke, type 2 diabetes, certain cancers, dementia, and multiple chronic diseases

Physical Benefits:

• Improved Mobility and Strength: Reduced joint pain, improved endurance, ability to engage in activities previously difficult or impossible
• Increased Energy: Higher baseline energy, less fatigue, better capacity for daily activities and exercise
• Improved Appearance: Weight loss creates noticeable physical transformation improving body confidence and self-image

Mental and Emotional Benefits:

• Improved Mood and Mental Health: Weight loss often improves depression and anxiety; many patients report significant mood elevation
• Increased Confidence: Dramatic improvement in body confidence and self-esteem
• Reduced Weight-Related Anxiety: Diminished worry about health implications of excess weight
• Improved Social Engagement: Increased willingness to participate in social activities, reduced social anxiety related to weight
• Sense of Accomplishment: Achievement of health goals creates powerful motivation for maintaining results

Long-Term Quality of Life Improvement:

Sustained weight loss and metabolic health create the foundation for healthier, longer, more active lives—enjoying activities, traveling, playing with family without physical limitations, and living free from weight-related health anxiety.

Who Is a Candidate for Medical Weight Loss with Semaglutide or Tirzepatide?

Our medical weight loss program may be ideal for you if:

Medical Criteria:

• BMI 30+ (obese): FDA approval for GLP-1/GIP agonists requires BMI ≥30, OR
• BMI 27–29.9 (overweight) with weight-related health conditions: Such as type 2 diabetes, prediabetes, hypertension, dyslipidemia (high cholesterol/triglycerides), sleep apnea, PCOS, or other obesity-related conditions
• Failed Multiple Prior Weight Loss Attempts: Those who’ve lost weight through diet/exercise but consistently regained it (indicating metabolic dysfunction rather than willpower failure)
• No Contraindications: No personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2, no active pancreatitis, no uncontrolled psychiatric conditions

Behavioral Criteria:

• Readiness for Lifestyle Change: Willingness to commit to nutrition and exercise improvements. Medication is a tool; lifestyle adherence determines results.
• Realistic Expectations: Understanding that weight loss is gradual (not overnight), requires sustained medication use, and success depends on long-term commitment.
• Medical Engagement: Willingness to attend regular follow-up appointments, participate in monitoring, and communicate openly about progress and challenges.

During your consultation, Dr. Snyder will assess whether you meet candidacy criteria and whether medication-supported weight loss is right for your situation. For some patients, additional evaluation or alternative approaches may be recommended.

Managing Side Effects: Realistic Expectations and Support

Both semaglutide and tirzepatide have side effect profiles. Understanding these helps you prepare and manage them effectively:

Common Side Effects (Mild to Moderate):

• Nausea: Most common side effect, especially during initial dose titration. Usually mild and resolves within days to weeks as the body adjusts. Strategies: take medication same time each day, eat smaller meals, avoid greasy foods, ginger tea or ginger supplements often help. If persistent, anti-nausea medication can be prescribed.
• Appetite Suppression (Expected): The mechanism of action—you may need to remind yourself to eat adequate calories and protein. Eat smaller, nutrient-dense meals. This is the desired effect but can require mindful eating to ensure adequate nutrition.
• Mild Gastrointestinal Discomfort: Constipation (common due to slowed gastric emptying) or diarrhea (less common). Strategies: increase water intake significantly, increase dietary fiber, light exercise. Dr. Snyder can recommend stool softeners or other medications if needed.
• Mild Fatigue: Some patients report energy decrease during dose titration; usually resolves as body adjusts. Ensure adequate calorie and protein intake, adequate sleep, and regular gentle exercise.
• Mild Headache: Occasional, usually resolves with hydration and over-the-counter pain management.
• Taste Changes: Some patients report altered food preferences or slight taste changes; temporary and resolves.

Serious Side Effects (Rare):

Serious side effects are uncommon in appropriate patients, but Dr. Snyder screens thoroughly for contraindications and monitors for any emerging concerns. Rare serious risks include acute pancreatitis (inflammation of the pancreas—extremely rare, but seek immediate attention if you develop severe abdominal pain), and allergic reactions (contact us immediately if you develop rash, difficulty breathing, or facial swelling).

Management Strategy:

Most side effects are manageable through dose timing adjustment, dietary changes, or specific supportive medications. If side effects are significant, Dr. Snyder may slow the dose escalation or temporarily reduce dose. The goal is finding the dose where weight loss benefits outweigh side effect burden. Open communication about your experience is critical.

Complementary Aesthetic Treatments: Addressing Loose Skin After Weight Loss

One common concern after significant weight loss is loose or sagging skin. Dermatology Laser Center and MediSpa offers multiple aesthetic treatments to address loose skin including:

Body Contouring and Muscle Enhancement:

EMSculpt NEO combines radiofrequency heating with high-intensity focused electromagnetic energy (HIFEM) to reduce fat, build muscle, and tighten loose skin on abdomen, flanks, thighs, arms, and buttocks. Ideal for post-weight-loss body refinement.

Skin Tightening Treatments:

Morpheus8 RF microneedling stimulates deep collagen remodeling, improving skin texture and tightness. Effective for face, neck, decollete, and body areas with mild-to-moderate skin laxity.

Laser skin resurfacing with fractional lasers improves texture and can provide modest tightening through collagen stimulation.

Sofwave ultrasound therapy delivers focused ultrasound energy for non-invasive collagen stimulation and skin tightening.

These treatments are optimally timed 3–6 months after completing weight loss (once loose skin has fully adjusted) and can dramatically improve confidence and aesthetic outcomes after your weight loss journey. Dr. Snyder can discuss options during your weight loss follow-ups.

Frequently Asked Questions About Medical Weight Loss

Schedule Your Medical Weight Loss Consultation Today

If you’ve struggled with weight loss despite your best efforts, if you’re tired of yo-yo dieting, or if you’re ready to achieve sustainable results with medical support, Dermatology Laser Center and MediSpa can help. Dr. Steven Barry Snyder, MD is board-certified and experienced in medical weight loss, offering both semaglutide and tirzepatide protocols customized to your unique needs.

During your consultation, Dr. Snyder will:

• Assess your weight loss history, metabolic health, and candidacy for medication-supported weight loss
• Discuss semaglutide vs. tirzepatide options based on your specific situation
• Review expected timeline and realistic weight loss outcomes
• Discuss nutrition, exercise, and behavioral components of the program
• Address any questions or concerns
• Create a personalized protocol if you’re a candidate

Our program is comprehensive, medically supervised, and designed for sustainable, long-term results. Weight loss is achievable. Your success is our goal.

Call (410) 356-0000 today or schedule your consultation online. Dermatology Laser Center and MediSpa serves patients throughout Owings Mills, Baltimore County, Northern Maryland, and beyond.